prof. dr. Karim Vermaelen
- ORCID iD
- 0000-0002-6787-8577
Show
Sort by
-
Defining the optimal setting for transcriptomic analyses on blood samples for response prediction in immunotherapy-treated NSCLC patients
-
- Journal Article
- A1
- open access
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
-
MIDRIXNEO-LUNG : safety and immunogenicity of a neoantigen-presenting autologous dendritic cell therapy in resected NSCLC patients
(2023) JOURNAL OF THORACIC ONCOLOGY. In Journal of Thoracic Oncology 18(11, Supplement). p.S526-S526 -
- Journal Article
- A1
- open access
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
-
- Journal Article
- A1
- open access
Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research
-
- Journal Article
- A1
- open access
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
The RNA Atlas expands the catalog of human non-coding RNAs (June, 10.1038/s41587-021-00936-1, 2021)
-
- Journal Article
- A1
- open access
Dendritic cell-based immunotherapy in lung cancer
-
- Journal Article
- A2
- open access
Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report